|
1
|
Algire GH and Chalkey HW: Vascular
reactions of normal and malignant tissues in vivo. I. Vascular
reactions of mice to wounds and to normal and neoplastic implants.
J Natl Cancer Inst. 6:73–85. 1945.
|
|
2
|
Folkman J and Shing Y: Angiogenesis. J
Biol Chem. 267:10931–10934. 1992.
|
|
3
|
Liao D and Johnson RS: Hypoxia: A key
regulator of angiogenesis in cancer. Cancer Metastasis Rev.
26:281–290. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gerhardt H and Semb H: Pericytes:
gatekeepers in tumour cell metastasis? J Mol Med. 86:135–144. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Baluk P, Morikawa S, Haskell A, Mancuso M
and McDonald DM: Abnormalities of basement membrane on blood
vessels and endothelial sprouts in tumors. Am J Pathol.
163:1801–1815. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Christian S, Winkler R, Helfrich I, et al:
Endosialin (Tem1) is a marker of tumor-associated myofibroblasts
and tumor vessel-associated mural cells. Am J Pathol. 172:486–494.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rettig WJ, Garin-Chesa P, Healey JH, Su
SL, Jaffe EA and Old LJ: Identification of endosialin, a cell
surface glycoprotein of vascular endothelial cells in human cancer.
Proc Natl Acad Sci USA. 89:10832–10836. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
St Croix B, Rago C, Velculescu V, et al:
Genes expressed in human tumor endothelium. Science. 289:1197–1202.
2000.PubMed/NCBI
|
|
9
|
Christian S, Ahorn H, Koehler A, et al:
Molecular cloning and characterization of endosialin, a C-type
lectin-like cell surface receptor of tumor endothelium. J Biol
Chem. 276:7408–7414. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
MacFadyen JR, Haworth O, Roberston D, et
al: Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and
is not selectively expressed on tumour endothelium. FEBS Lett.
579:2569–2575. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
MacFadyen J, Savage K, Wienke D and Isacke
CM: Endosialin is expressed on stromal fibroblasts and CNS
pericytes in mouse embryos and is downregulated during development.
Gene Expr Patterns. 7:363–369. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Brady J, Neal J, Sadakar N and Gasque P:
Human endosialin (tumor endothelial marker 1) is abundantly
expressed in highly malignant and invasive brain tumors. J
Neuropathol Exp Neurol. 63:1274–1283. 2004.PubMed/NCBI
|
|
13
|
Kaur B, Khwaja FW, Severson EA, Matheny
SL, Brat DJ and Van Meir EG: Hypoxia and the
hypoxia-inducible-factor pathway in glioma growth and angiogenesis.
Neuro Oncol. 7:134–153. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Simonavicius N, Robertson D, Bax DA, Jones
C, Huijbers IJ and Isacke CM: Endosialin (CD248) is a marker of
tumor-associated pericytes in high-grade glioma. Mod Pathol.
21:308–315. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Davies G, Cunnick GH, Mansel RE, Mason MD
and Jiang WG: Levels of expression of endothelial markers specific
to tumour-associated endothelial cells and their correlation with
prognosis in patients with breast cancer. Clin Exp Metastasis.
21:31–37. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rmali KA, Puntis MC and Jiang WG:
Prognostic values of tumor endothelial markers in patients with
colorectal cancer. World J Gastroenterol. 11:1283–1286. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dolznig H, Schweifer N, Puri C, et al:
Characterization of cancer stroma markers: in silico analysis of an
mRNA expression database for fibroblast activation protein and
endosialin. Cancer Immun. 5:102005.PubMed/NCBI
|
|
18
|
Rupp C, Dolznig H, Puri C, et al: Mouse
endosialin, a C-type lectin-like cell surface receptor: expression
during embryonic development and induction in experimental cancer
neoangiogenesis. Cancer Immun. 6:102006.
|
|
19
|
Virgintino D, Girolamo F, Errede M, et al:
An intimate interplay between precocious, migrating pericytes and
endothelial cells governs human fetal brain angiogenesis.
Angiogenesis. 10:35–45. 2007. View Article : Google Scholar
|
|
20
|
Carson-Walter EB, Watkins DN, Nanda A,
Vogelstein B, Kinzler KW and St Croix B: Cell surface tumor
endothelial markers are conserved in mice and humans. Cancer Res.
61:6649–6655. 2001.PubMed/NCBI
|
|
21
|
Nanda A, Karim B, Peng Z, et al: Tumor
endothelial marker 1 (Tem1) functions in the growth and progression
of abdominal tumors. Proc Natl Acad Sci USA. 103:3351–3356. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tomkowicz B, Rybinski K, Foley B, et al:
Interaction of endosialin/TEM1 with extracellular matrix proteins
mediates cell adhesion and migration. Proc Natl Acad Sci USA.
104:17965–17970. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bagley RG: Human endothelial precursor
cells express tumor endothelial marker 1/endosialin/CD248. Mol
Cancer Ther. 8:2536–2546. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bagley RG: Endosialin-TEM 1-CD248 is a
pericyte marker of embryonic and tumor neovascularization.
Microvasc Res. 76:180–188. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tomkowicz B, Rybinski K, Sebeck D, Sass P,
Nicolaides NC, Grasso L and Zhou Y: Endosialin/TEM-1/CD248
regulates pericyte proliferation through PDGF receptor signaling.
Cancer Biol Therapy. 9:908–915. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Maia M, DeVriese A, Janssens T, Moons M,
Lories RJ, Tavernier J and Conway EM: CD248 facilitates tumor
growth via its cytoplasmic domain. BMC Cancer. 11:1622011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Perzelova A, Macikova I, Mraz P, Bizik I
and Steno J: Characterization of two new permanent glioma cell
lines 8-MG-BA and 42-MG-BA. Neoplasma. 45:25–29. 1998.PubMed/NCBI
|
|
28
|
Kontsekova E, Novak M, Kontsek P, Borecky
L and Lesso J: The effect of postfusion cell density on
establishment of hybridomas. Folia Biol (Praha). 34:18–22.
1988.PubMed/NCBI
|
|
29
|
Ohradanova A, Gradin K, Barathova M, et
al: Hypoxia upregulates expression of human endosialin gene via
hypoxia-inducible factor 2. Br J Cancer. 99:1348–1356. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Carson-Walter EB, Winnans BN, Whiteman MC,
et al: Characterization of TEM1/endosialin in human and murine
brain tumors. BMC Cancer. 9:4172009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Semenza GL: Regulation of mammalian O2
homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol.
15:551–578. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Carmeliet P and Jain RK: Angiogenesis in
cancer and other diseases. Nature. 407:249–257. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Semenza GL: HIF-1: using two hands to flip
the angiogenic switch. Cancer Metastasis Rev. 19:59–65. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Verheul HMW, Voest EE and Schlingemann RO:
Are tumours angiogenesis-dependent? J Pathol. 202:5–13. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Opavsky R, Haviernik P, Jurkovicova D, et
al: Molecular characterization of the mouse Tem1/endosialin gene
regulated by cell density in vitro and expressed in normal tissues
in vivo. J Biol Chem. 276:38795–38807. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kondo K, Kohno N, Yokoyama A and Hiwada K:
Decreased MUC1 expression induces E-cadherin mediated cell adhesion
of breast cancer cell lines. Cancer Res. 58:2014–2019.
1998.PubMed/NCBI
|
|
37
|
Wesseling J, van der Valk SW and Hilkens
J: A mechanism for inhibition of E-cadherin-mediated cell-cell
adhesion by the membrane-associated mucin episialin/MUC1. Mol Biol
Cell. 7:565–577. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wesseling J, van der Valk SW, Vos HL,
Sonnenberg A and Hilkens J: Episialin (MUC1) overexpression
inhibits integrin-mediated cell adhesion to extracellular matrix
components. J Cell Biol. 129:255–265. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kohlgraf KG, Gawron AJ, Higashi M, et al:
Contribution of the MUC1 tandem repeat and cytoplasmic tail to
invasive and metastatic properties of a pancreatic cancer cell
line. Cancer Res. 63:5011–5020. 2003.PubMed/NCBI
|
|
40
|
Komatsu M, Carraway CA, Fregien NL and
Carraway KL: Reversible disruption of cell-matrix and cell-cell
interactions by overexpression of sialomucin complex. J Biol Chem.
272:33245–33254. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Komatsu M, Tatum L, Altman NH, Carothers
Carraway CA and Carraway KL: Potentiation of metastasis by cell
surface sialomucin complex (rat MUC4), a multifunctional
anti-adhesive glycoprotein. Int J Cancer. 87:480–486. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Komatsu M, Yee L and Carraway KL:
Overexpression of sialomucin complex, a rat homologue of MUC4,
inhibits tumor killing by lymphokine-activated killer cells. Cancer
Res. 59:2229–2236. 1999.
|
